Beta Drugs Limited

Web: betadrugslimited.com NSE: BETA SECTOR: Healthcare - Pharmaceuticals & Biotechnology

1440 40(3%)

Volume

-

Open

0

High

0

Low

0

Close

1,400

VWAP

0

52 Week High

2,000

52 Week Low

990

Viand Research Rating
Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

1,460

No. of Shares

1.01

P/E

-

P/B

-

Face Value

-

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

-

ROCE

-

Profit Growth

-

Listing Date

12-Oct-17

Promoter Holding

64.63%

FII Holding

1.16%

DII Holding

2.15%

Price Chart
Price Performance
1 Week0
1 Month0
3 Months0
6 Months0
1 Year0
YTD0
Moving Average
5 Day SMA0
10 Day SMA0
20 Day SMA0
30 Day SMA0
50 Day SMA0
61 Day SMA0
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqDiv Yld %NP Qtr Rs.Cr.
1SUNPHARMA4,42,18718432%14%2%9%39000
2DIVISLAB1,80,28067912%6%4%1%65000
3TORNTPHARM1,53,28145290%8%18%40%64000
4APOLLOHOSP1,19,04782803%7%12%17%58000
5CIPLA1,14,86914221%10%7%4%22000
6DRREDDY1,11,01513300%1%7%7%20000
7ZYDUSLIFE1,09,37810876%16%15%17%20000
8LUPIN1,04,01722751%2%9%15%23000
9MANKIND1,00,48224343%7%7%2%49000
10MAXHEALTH96,8679957%1%15%14%0000
Load More
Shareholding Pattern (%)
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(-0.31) 64.63%(-1.81) 64.90%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.73%(0.01) 66.71%(0.01) 66.71%(0.01) 66.71%(0.01) 66.71%(0.01) 66.71%(0.01) 66.68%
FIIs(0.01) 1.16%(0.21) 1.14%(0.01) 0.90%(0.01) 0.90%(-0.31) 0.90%(0.01) 1.15%(0.31) 1.16%(0.61) 0.90%(0.01) 0.32%(0.01) 0.32%(0.01) 0.32%(0.01) 0.29%(0.01) 0.29%(0.01) 0.29%(0.31) 0.29%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
DIIs(0.31) 2.15%(1.61) 1.90%(0.01) 0.29%(0.11) 0.26%(0.01) 0.17%(0.01) 0.17%(0.01) 0.16%(0.11) 0.12%(0.01) 0.06%(0.01) 0.02%(0.01) 0.02%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(-0.31) 0.04%(0.01) 0.29%(0.01) 0.29%(0.01) 0.29%(0.01) 0.28%
Public32.06%32.07%32.07%32.11%32.20%31.95%31.95%32.25%32.87%32.92%32.93%32.93%32.94%32.96%32.96%33.00%33.00%33.01%33.03%
No. of Shareholders4,7363,6943,1843,1393,0542,8822,5672,3232,1161,9281,7221,4511,4241,4441,4071,296762675542
Quarterly Results
Mar 2026Dec 2025Sep 2025Mar 2025Dec 2024Sep 2024Mar 2024Sep 2023Mar 2023Sep 2022Mar 2022Sep 2021Mar 2021Sep 2020Mar 2020Sep 2019
Sales93.9687.27103.3993.7688.29180154141115112968865514447
Expenses76.2870.2982.0976.4169.831411271088886736851413637
Operating Profit17.6816.9821.317.3518.4639273326272320141189
OPM %18.8219.4620.618.520.912218232324242322211920
Other Income2.892.312.991.74-1.3821100000000
Interest3.944.433.613.291.8821111111121
Depreciation4.84.394.243.573.2464565434322
Profit before tax11.8310.4716.4412.2311.96332227202118169757
Tax %23.518.6225.7326.1725.172525252525272830211427
Net Profit 9.058.5212.229.038.95241720151613127545
EPS in Rs8.938.412.118.958.8624.216.419.6714.7315.6712.9511.636.485.134.255.07
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Sales385362296227184116916651
Expenses30928823617414191735441
Operating Profit76756053432518129
OPM %202120232321201819
Other Income1121110000
Interest1573222311
Depreciation1713101077432
Profit before tax5457494134161287
Tax %24262525282721-21
Net Profit 414236312512987
EPS in Rs40.9242.0236.0830.4224.5811.69.338.847.43
Dividend Payout %000000000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Cash from Operating Activity036312330198017
Cash from Investing Activity0-36-14-19-22-6-15-21-11
Cash from Financing Activity0118-7-2-1-89125
Net Cash Flow011892752-912
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Equity Capital10101010101010101099
Reserves2352111871711481138359483224
Borrowings148146138191520211723208
Other Liabilities103121101958255453128229
Total Liabilities4964884362952541981581181078350
Fixed Assets125112896665635540441813
CWIP000000030151
Investments00000111000
Other Assets37137634722919013510274635035
Total Assets4964884362952541981581181078350
Delivery
#Date
1050
59%
1665
Value (Cr)Q/T
13		Del
55		Del
2
127-May1442
2
9571
226-May1400
4
9442
325-May1369
5
16573
422-May1377
11
15415
521-May1237
1
14651
620-May1215
3
11441
719-May1192
3
17692
818-May1216
4
13552
915-May1272
8
10474
1014-May1404
2
7591
1113-May1417
4
9572
1212-May1362
2
10631
1311-May1342
2
15712
148-May1322
2
19491
157-May1359
3
12451
166-May1352
1
11621
175-May1320
1
16741
184-May1316
1
11570
1930-Apr1330
1
12631
2029-Apr1305
1
15691
2128-Apr1302
1
13490
2227-Apr1313
1
10660
2324-Apr1336
1
11740
2423-Apr1328
1
12511
2522-Apr1324
3
11471
2621-Apr1316
1
11551
2720-Apr1334
1
8660
2817-Apr1376
1
10741
2916-Apr1387
0
5660
3015-Apr1390
1
7591
3113-Apr1401
1
9551
3210-Apr1394
1
7591
339-Apr1417
1
7490
348-Apr1452
2
7531
357-Apr1525
4
8271
366-Apr1549
3
9331
372-Apr1387
3
8441
381-Apr1270
2
11531
3930-Mar1189
6
12473
4027-Mar1165
2
8561
4125-Mar1202
5
8392
4224-Mar1073
1
11701
4323-Mar1068
1
9521
4420-Mar1106
2
22832
Daily Market Cap
DateTotal Market CapChangeChg %
28-May1,460c14c0.97
27-May1,446c26c1.80
26-May1,420c36c2.63
25-May1,384c86c6.65
22-May1,298c64c5.21
21-May1,233c12c0.96
20-May1,222c25c2.11
19-May1,196c9c0.78
18-May1,206c72c5.60
15-May1,277c151c10.57
14-May1,428c50c3.60
12-May1,379c35c2.56
11-May1,344c24c1.78
07-May1,369c5c0.37
06-May1,363c23c1.75
05-May1,340c20L0.02
04-May1,340c9c0.68
30-Apr1,349c29c2.17
29-Apr1,321c10c0.76
28-Apr1,311c37c2.75
24-Apr1,348c4c0.27
23-Apr1,344c13c0.99
22-Apr1,331c20c1.44
21-Apr1,350c36c2.62
17-Apr1,387c27c1.94
15-Apr1,414c00
Stock Checklist
Price is below from 52 week high low average: 11%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0